Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 101–124 of 124 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01334177	TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck	completed	Phase 1	13	University of WashingtonOTHER	1	Mar 5, 2015	clinicaltrials
NCT00101348	Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer	completed	Phase 1 / Phase 2	66	National Cancer Institute (NCI)NIH	1